Catalyst Wire Dossier Catalyst Wire Dossier

EMROSI

MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE · Journey Medical Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EMROSI, covering 2024-11-01 to 2024-11-01. Get the full timeline:

Most recent: FDA Approved: EMROSI — Original Application (Journey Medical Corporation)

See pricing